Safety of topical corticosteroids in pregnancy

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Chi, Ching Chi ^a   Lee, Chia Wen ^b   Wojnarowska, Fenella ^c   Kirtschig, Gudula ^d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE;

APGAR SCORE; CLEFT LIP; CLEFT PALATE; CLINICAL TRIAL; CONGENITAL DISORDER; DELIVERY; DRUG SAFETY; ECZEMA; FIRST TRIMESTER PREGNANCY; HUMAN; INFORMATION PROCESSING; LOW BIRTH WEIGHT; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; REVIEW; SAMPLE SIZE; STILLBIRTH; SYSTEMATIC REVIEW; URTICARIA;

EID: 70049085670     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007346.pub2     Document Type: Review

References (64)

1. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal corticosteroid use and orofacial clefts. American Journal of Obstetrics and Gynecology 2007;197(6):585.e1-585.e7. (Pubitemid 350166247)
2. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology 1997;56(5):335-340 (Pubitemid 28035180)
3. Edwards MJ, Agho K, Attia J, Diaz P, Hayes T, Illingworth A, et al.Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. American Journal of Medical Genetics Part A 2003;120(4):459-463 (Pubitemid 37063739)
4. Källén B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. The Cleft Palate-Craniofacial Journal 2003;40(6):624-628 (Pubitemid 37429691)
5. Mahé A, Perret JL, Ly F, Fall F, Rault JP, Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007;101(2):183-187. (Pubitemid 44835343)
6. Mygind H, Thulstrup AM, Pedersen L, Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2002;81(3):234-239 (Pubitemid 34264139)
7. Pradat P, Robert-Gnansia E, Di Tanna GL, Rosano A, Lisi A, Mastroiacovo P, et al.First trimester exposure to corticosteroids and oral clefts. Birth Defects Research 2003;67(12):968-970 (Pubitemid 38018036)
8. Altman DG. Practical Statistics for Medical Research. 1st Edition. London: Chapman & Hall, 1991.
9. Ambros-Rudolph CM. Dermatoses of pregnancy. Journal der Deutschen Dermatologischen Gesellschaft 2006;4(9):748-761 [: doi: 10.1111/j.1610-0387. 2006.06008.x]
10. Anderson GG, Rotchell Y, Kaiser DG. Placental transfer of methylprednisolone following maternal intravenous administration. American Journal of Obstetrics and Gynecology 1981;140(6):699-701. (Pubitemid 11046355)
11. Arosarena OA. Cleft lip and palate. Otolaryngologic Clinics of North America 2007;40:27-60.
12. Ballard PL, Granberg P, Ballard RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. Journal of Clinical Investigation 1975;56(6):1548-1554
13. Ballard PD, Hearney EF, Smith MB. Comparative teratogenicity of selected glucocorticoids applied ocularly in mice. Teratology 1977;16(2):175-180
14. Baumann L, Kerdel F. Topical glucocorticoids. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al. editor (s). Fitzpatrick's Dermatology in General Medicine. 5th Edition. New York: McGraw-Hill, 1999:2713-2717
15. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term. The Journal of Pediatrics 1972;81(5):936-945
16. Berth-Jones J. Topical therapy. In: Burns T, Breathnach SM, Cox N, Griffiths C editor(s). Rook's Textbook of Dermatology. 7th Edition. Oxford: Blackwell Publishing, 2004:75.1-52
17. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Drugs in Pregnancy and Lactation. 8th Edition. Philadelphia: Lippincott Williams & Wilkins, 2008.
18. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. American Journal of Medical Genetics 1999;86(3):242-244 (Pubitemid 29465870)
19. Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. New England Journal of Medicine 2001;344(7):467-471 (Pubitemid 32164897)
20. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, III, Wenstrom KD. Williams Obstetrics. 22nd Edition. New York: McGraw-Hill, 2005.
21. Czeizel AE. Birth defects are preventable. International Journal of Medical Sciences 2005;2(3):91-92
22. Devane D, Begley CM, Clarke M, Horey D, O'Boyle C. Evaluating maternity care: A core set of outcome measures. Birth 2007;34(2):164-172. (Pubitemid 46848925)
23. Gitau R, Cameron A, Fisk NM, Glover V. Fetal exposure tomaternal cortisol. Lancet 1998;352(9129):707-708
24. Gitau R, Fisk NM, Teixeira JM, Cameron A, Glover V. Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses. Journal of Clinical Endocrinology and Metabolism 2001;86(1):104-109 (Pubitemid 32109782)
25. GlaxoSmithKline. Cutivate cream prescribing information. Pharmaceutical Information 2002.
26. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reproductive Toxicology 2004;18(1):93-101. (Pubitemid 38175451)
27. Hale EK, Pomeranz MK. Dermatologic agents during pregnancy and lactation: An update and clinical review. International Journal of Dermatology 2002;41(4):197-203. (Pubitemid 34601121)
28. Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB. Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database. Pharmacoepidemiology and Drug Safety 2006;15(8):555-564
29. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. Journal of the American Academy of Dermatology 2006;54(1):1-18.
30. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2008.
31. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. American Journal of Respiratory and Critical Care Medicine 1997;156(1):178-184 (Pubitemid 27293185)
32. Jessop S, Whitelaw D, Jordaan F. Drugs for discoid lupus erythematosus. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: DOI: 10.1002/14651858.CD002954]
33. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-46 (Pubitemid 32682008)
34. Katz VL, Thorp Jr JM, Bowes Jr WA. Severe symmetric intrauterine growth retardation associated with the topical use of triamcinolone. American Journal of Obstetrics and Gynecology 1990;162(2):396-397
35. Khumalo N, Kirtschig G, Middleton P, Hollis S, Wojnarowska F, Murrell D. Interventions for bullous pemphigoid. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD002292.pub2]
36. Leachman SA, Reed BR. The use of dermatologic drugs in pregnancy and lactation. Dermatologic Clinics 2006;24(2):167-197
37. Marsland AM, Chalmers RJG, Hollis S, Leonardi-Bee J, Griffiths CEM. Interventions for chronic palmoplantar pustulosis. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD001433.pub2]
38. Meadows M. Pregnancy and the drug dilemma. FDA Consumer 2001;35(3):16-20.
39. Mehta DK. British National Formulary. British National Formulary. 2nd Edition. BMJ Publishing Group Ltd and RPS Publishing, 2006: BMJ Publishing Group Ltd and RPS Publishing 2006.
40. Murphy BE, Clark SJ, Donald IR, Pinsky M, Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. American Journal of Obstetrics and Gynecology 1974;118(4):538-541
41. Murphy VE, Fittock RJ, Zarzycki PK, Delahunty MM, Smith R, Clifton VL. Metabolism of synthetic steroids by the human placenta. Placenta 2007;28(1):39-46. (Pubitemid 44734614)
42. Nanda R, van der Linden FP, Jansen HW. Production of cleft palate with dexamethasone and hypervitaminosis A in rat embryos. Experientia 1970;26(10):1111-1112
43. Narama I. Reproduction studies of diflorasone diacetate (DDA) (4) Teratogenicity study in rabbits by percutaneous administration. Pharmacometrics 1984;28(2):241-250 (Pubitemid 14009374)
44. Nasjleti CE, Avery JK, Spencer HH, Walden JM. Tritiated cortisone distribution and induced cleft palate in mice. Journal of Oral Therapeutics and Pharmacology 1967;4(1):71-82.
45. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al.Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62(6):385-392
46. Petersen MC, Nation RL, Ashley JJ, McBride WG. The placental transfer of betamethasone. European Journal of Clinical Pharmacology 1980;18(3):245-247
47. Rodriguez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998;58(1):2-5. (Pubitemid 28404243)
48. Schering. ELOCON cream prescribing information. Pharmaceutical Information 2003.
49. Shah RM, Kilistoff A. Cleft palate induction in hamster fetuses by glucocorticoid hormones and their synthetic analogues. Journal of Embryology and Experimental Morphology 1976;36(1):101-108
50. Sifton DW. Physicians' Desk Reference. 6th Edition. Montvale: Medical Economics Company, 2002.
51. Smith MA, Thomford PJ, Mattison DR, Slikker W, Jr. Transport and metabolism of dexamethasone in the dually perfused human placenta. Reproductive Toxicology 1988;2(1):37-43.
52. Stanier P, Moore GE. Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. Human Molecular Genetics 2004;13(1):R73-81. (Pubitemid 38443801)
53. Sun K, Yang K, Challis JR. Glucocorticoid actions and metabolism in pregnancy: implications for placental function and fetal cardiovascular activity. Placenta 1998;19(5-6):353-360 (Pubitemid 28327693)
54. Taro Pharmaceuticals. Diflorasone diacetate cream prescribing information. Pharmaceutical Information 1999.
55. Thomson Healthcare. DRUGDEX® Evaluations. Thomson Micromedex 2009; Vol.140.
56. Turpeinen M, Mashkilleyson N, Bjorksten F, Salo OP. Percutaneous absorption of hydrocortisone during exacerbation and remission of atopic dermatitis in adults. Acta Dermato-Venereologica 1988;68(4):331-335 (Pubitemid 18188563)
57. Turpeinen M. Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis. European Journal of Pediatrics 1989;148(8):729-731 (Pubitemid 19186729)
58. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, et al.Neurotoxicity of glucocorticoids in the primate brain. Hormones and Behavior 1994;28(4):336-348
59. Walker BE. Induction of cleft palate in rabbits by several glucocorticoids. Proceedings of the Society for Experimental Biology and Medicine 1967;125(4):1281-1284
60. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.ohri.ca/programs/clinical-epidemiology/oxford.htm (accessed 23 November 2006).
61. Womersley J, Stone DH. Epidemiology of facial clefts. Archives of Disease in Childhood 1987;62(7):717-720
62. Wong FK, Hagg U. An update on the aetiology of orofacial clefts. Hong Kong Medical Journal 2004;10(5):331-336
63. Yamada H, Nakano M, Ichihashi T. Fetal concentration after topical application of betamethasone 17,21-dipropionate (S-3440) ointment and teratogenesis in mice and rabbits. Pharmacometrics 1981;21(4):645-655 (Pubitemid 11012637)
64. Zip C. A practical guide to dermatological drug use in pregnancy. Skin Therapy Letter 2006;11(4):1-4.